Previous Article | Next Article ![]()
Infection and Immunity, January 2009, p. 446-455, Vol. 77, No. 1
0019-9567/09/$08.00+0 doi:10.1128/IAI.00312-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of Pathobiological Sciences, University of Wisconsin-Madison, School of Veterinary Medicine, Madison, Wisconsin
Received 9 March 2008/ Returned for modification 18 April 2008/ Accepted 27 October 2008
|
|
|---|
30 kDa. Peptide sequences for the 30-kDa BBEC-binding proteins, as determined by liquid chromatography-tandem mass spectrometry, matched two M. haemolytica surface proteins: heat-modifiable outer membrane protein A (OmpA) and lipoprotein 1 (Lpp1). Western blotting showed that the 30-kDa protein band is recognized by both anti-M. haemolytica OmpA and anti-Lpp1 antibodies. Furthermore, incubation with anti-OmpA and anti-Lpp1 antibodies significantly inhibited M. haemolytica binding to BBEC monolayers. In summary, these results suggest that OmpA and Lpp1 contribute to adherence of M. haemolytica to bovine respiratory epithelial cells. |
|
|---|
The adherence of respiratory pathogens to the mucosal epithelium is a critical step in host colonization and infection (1). Previous studies demonstrated the ability of M. haemolytica to adhere to epithelial cells in vitro (7, 20, 52) and the mucosal surface of respiratory tissue explants (8, 34). M. haemolytica produces several surface components that potentially can contribute to adherence. Fimbriae and glycocalyx were identified on M. haemolytica cells grown in culture and on bacteria associated with tracheal tissues isolated from experimentally infected cows (33, 34). However, the role of these structures in M. haemolytica adhesion has never been investigated. Similar to other gram-negative bacteria, M. haemolytica produces major outer membrane protein A (OmpA) (31, 55). This protein is also referred to as heat-modifiable outer membrane protein (OMP) or, in M. haemolytica, PomA (2, 31, 55). OmpA participates in specific binding to cell receptors and mediates adherence of several pathogenic bacteria to host cells (4, 12, 45, 46, 51). Based on sequence homology, it has been suggested that the OmpA of M. haemolytica might play a role in colonization of the respiratory tracts of cattle and sheep (13). M. haemolytica cells also express a high-molecular-weight protein, similar to the high-molecular-weight and Hia adhesin proteins of Haemophilus influenzae, but its functional activity and interaction with target cells have not been reported (30). A 68-kDa adhesin with hemagglutinating activity for rabbit erythrocytes specifically recognizes glycoproteins containing N-acetyloglucosamine (GlcNAc) on bovine neutrophils and tracheal epithelial cells (14, 23). Binding of this 68-kDa adhesin to bovine neutrophils induces an oxidative burst (14).
Genome sequence analysis of M. haemolytica revealed a wide repertoire of putative adhesins similar to those characterized in other respiratory pathogens (21). These include filamentous hemagglutinin FhaB, as described in Bordetella pertussis, two trimeric autotransporter adhesins resembling those of H. influenzae and Neisseria meningitidis, and proteins with dual immunoglobulin protease/adhesin function that have orthologues in H. influenzae and N. meningitidis. It is not known whether these proteins are expressed by M. haemolytica cells or play any role in its adhesion to bovine respiratory epithelial cells.
In the present study, we sought to identify M. haemolytica proteins that interact with bovine bronchial epithelial cells (BBEC) and are involved in bacterial adherence. For this purpose, biotinylated M. haemolytica surface proteins were analyzed for binding to BBEC monolayers. We identified at least two 30-kDa proteins, heat-modifiable OmpA and lipoprotein 1 (Lpp1), which associate with BBEC and are candidate adhesins. We also demonstrate for the first time the utility of using fixed monolayers of epithelial cells for affinity purification of bacterial adhesins.
|
|
|---|
(Invitrogen) was used for both plasmid generation and recombinant protein expression. For cloning experiments, E. coli cultures were grown in Luria-Bertani medium (43) supplemented with 100 µg/ml of ampicillin. For recombinant protein expression, the bacteria were grown in BHI broth supplemented with 100 µg/ml of ampicillin. Primary BBEC. Primary BBEC were kindly provided by D. S. Allen-Gipson (Omaha, NE). BBEC were maintained at 37°C in 5% CO2 in Dulbecco's modified Eagle's medium/F-12 medium (Mediatech, Inc.) supplemented with 10% heat-inactivated fetal bovine serum, 2 mM glutamine, and Pen/Strep (Sigma), for up to 12 to 14 passages.
FITC labeling of bacteria.
Overnight cultures of M. haemolytica were centrifuged and washed with phosphate-buffered saline (PBS). The bacteria (
2 x 109) were added to 10 ml of 0.01% fluorescein isothiocyanate (FITC; Sigma) in 0.2 M Na2CO3/NaHCO3 buffer, pH 9.6, and incubated on ice for 15 min. Bacterial cells were then washed and resuspended in RPMI medium at a final concentration of 1 x 108 CFU/ml.
Fluorescence microscopy. Confluent BBEC monolayers in 24-well tissue culture plates were washed with RPMI medium and incubated with FITC-labeled M. haemolytica at a multiplicity of infection (MOI) of 100 bacterial cells per epithelial cell (MOI of 100:1) for 2 h at 37°C in 5% CO2. Unbound bacteria were removed by five washes with RPMI medium. Cell-associated bacteria were visualized by fluorescence microscopy using an Olympus IX70 microscope (Olympus). In some experiments, FITC-labeled M. haemolytica (2.5 x107) was preincubated for 45 min at room temperature with a 1:100 dilution of rabbit polyclonal anti-M. haemolytica antibody (a generous gift from R. Y. C Lo, Guelph, Canada) or normal rabbit serum (Cappel Laboratories) before bacteria were added to BBEC.
Adhesion and invasion assay.
Confluent BBEC monolayers in 24-well tissue culture plates (approximately 2.5 x105 cells per well) were washed with RPMI medium and incubated with M. haemolytica (MOI of 100:1) for 2 h at 37°C in 5% CO2 or at 4°C without 5% CO2. The epithelial cells were then washed five times with RPMI medium and lysed with 1% saponin (Sigma) in RPMI medium for 20 min at room temperature to release adherent bacteria. The number of CFU in each well was quantified by plating serial dilutions of cell lysates on blood agar plates. In some experiments, binding of E. coli DH5
to BBEC was analyzed as a control in a similar manner. To analyze whether internalization of M. haemolytica occurred, we performed a gentamicin protection assay. Briefly, BBEC monolayers were incubated with M. haemolytica (MOI of 100:1) for 1 and 3 h at 37°C in 5% CO2. After five washes with RPMI medium, epithelial cells were incubated for an additional 1 h with 100 µg/ml gentamicin. BBEC were then washed three times with RPMI medium to remove antibiotic, lysed as described above, and plated on blood agar plates to enumerate the CFU of bacteria.
Biotinylation of bacterial surface proteins. An overnight culture of M. haemolytica (200 ml) was centrifuged and washed with PBS. The bacteria were mixed with 2 ml of biotinamidocaproate-N-hydroxysuccinimide ester (Sigma) in PBS (0.025%, wt/vol, solution) and incubated at room temperature for 1 h with gentle shaking. The bacterial cells were collected by centrifugation, washed three times, and resuspended in 1 ml of PBS. The bacterial cells were sonicated three time (45 s each) on ice, using a Vibra Cell sonicator (Sonics and Materials, Inc.), and centrifuged for 10 min at 10,000 x g. The protein concentration in the resulting supernatants was determined using a bicinchoninic acid assay (Pierce).
Isolation of OMPs. M. haemolytica OMPs were isolated as described by Shin et al. (46) with minor modifications. Briefly, a bacterial culture (1 liter) was harvested by centrifugation and exposed to two freeze-thaw cycles on dry ice. The bacterial pellet was resuspended in 20 ml of 10 mM HEPES, pH 7.4, containing lysozyme (5 mg/ml; Pierce), DNase I (40 µg/ml; Roche), and RNase A (100 µg/ml; Sigma) and then incubated at 4°C for 30 min. Cells were disrupted by sonication (three times for 1 min each time) on ice, using a Vibra Cell sonicator, in the presence of a protease inhibitor cocktail (1:20; Sigma). After centrifugation (6,500 x g, 5 min), the bacterial cell lysate was subjected to ultracentrifugation at 25,000 rpm in an SW28 rotor (Beckman Coulter) at 15°C for 1 h. The pellet containing the crude cell envelope was washed with cold PBS and extracted with 5 ml of 2% Sarkosyl (N-lauroylsarcosine; in PBS) for 30 min at room temperature. Sarkosyl-insoluble outer membrane fractions were pelleted at 30,000 rpm in an SW41 rotor for 1 h and solubilized in 10 mM HEPES (pH 7.4), containing 0.7% n-octyl-glucoside (Research Products International Corp.). In some experiments, isolated OMPs were biotinylated according to the method described by Duk et al. (17), with minor modifications. Briefly, 200 µg of OMP resuspended in 250 µl of PBS containing 0.7% n-octyl-glucoside was mixed with 400 of µl 0.025% solution of biotinamidocaproate-N-hydroxysuccinimide ester (Sigma) and incubated for 1 h at room temperature. The proteins were dialysed for several hours against PBS at 4°C.
Binding of biotinylated proteins to BBEC monolayers. BBEC growing in six-well plates were washed with PBS and incubated with bacterial lysates containing biotinylated surface proteins (100 to 200 µg per well) or with biotinylated OMPs (30 µg per well) for 1.5 h at room temperature. The cell monolayers were washed five time with PBS and then lysed with 150 µl of mammalian protein extraction reagent (M-PER; Pierce). Total proteins were mixed with Laemmli loading buffer and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in a 4 to 20% gradient gel. Proteins were blotted onto nitrocellulose (Bio-Rad) and probed with a 1:10,000 dilution of horseradish peroxidase (HRP)-conjugated anti-biotin antibody (Sigma) or a 1:250 dilution of rabbit polyclonal anti-M. haemolytica antibody, followed by 1:3,000 dilution of HRP-conjugated anti-rabbit antibody (Santa Cruz Biotechnology, Inc.). The ESL Western Chemiluminescence Reagent Plus (Pierce) was used to visualize proteins. In separate experiments, binding of biotinylated bacterial proteins to fixed BBEC monolayers was evaluated. BBEC were treated with Karnovsky's fixative (mixture 2, containing 2% paraformaldehyde, 2.5% glutaraldehyde, and 0.1 M sodium phosphate buffer; Electron Microscopy Sciences) for 10 min at room temperature and then washed two times with PBS before they were incubated with biotinylated M. haemolytica proteins as described above.
Isolation and identification of BBEC-binding proteins. BBEC monolayers in T75 flasks were washed with PBS and fixed with Karnovsky's fixative (mixture 2; Electron Microscopy Sciences) for 10 min at room temperature. The fixed cells were washed two times with PBS and incubated overnight with the M. haemolytica OMP fraction (200 µg/ml) at 4°C. Unbound proteins were removed by washing five times with PBS. Bound proteins were eluted from cell monolayers using M-PER (Pierce) and concentrated using a Centricon YM-10 column (Millipore). The proteins (20 µg) were mixed with SDS boiling buffer (5% SDS, 10% glycerol, 60 mM Tris, pH 6.8, 5% mercaptoethanol) and subjected to two-dimensional electrophoresis (2-DE; Kendrick Labs, Inc., Madison, WI). The gel was stained with Coomassie blue, dried between sheets of cellophane, and digitally scanned. The proteins of interest (30 kDa) were excised from the Coomassie blue-stained gels and submitted for liquid chromatography (LC)-electrospray ionization tandem mass spectrometry (MS/MS) analysis (Protein Core Facility of the Columbia University Medical Center, New York, NY). Analysis of MS/MS spectral data was performed using Mascot software (http://www.matrixscience.com).
Alternatively, fixed BBEC monolayers were incubated with M. haemolytica whole-cell lysates in PBS (1 mg/ml). Bacterial proteins bound to BBEC were eluted using 1x Laemmli buffer and concentrated as described above. The proteins were separated by SDS-PAGE in 4 to 20% gradient gels and stained with Coomassie blue or transferred into nitrocellulose and probed with bovine polyclonal anti-M. haemolytica OmpA (a generous gift from A. W. Confer, Stillwater, OK) or chicken anti-M. haemolytica rLpp1 antibodies.
Plasmid construction. The M. haemolytica lpp1 gene was amplified by PCR from total M. haemolytica genomic DNA using the following pair of primers: lpp5', 5'-GGCGCATGCCATGAGTTTCAAGAAAATTTTAG-3'; and lpp3', 5'-GTTCCGCGGCCAACCTTTTACTACAC-3'. The PCR product was cloned into the dsRed vector (Clontech), in which the dsRed gene was replaced with a DNA segment encoding antigen V5 and a His tag (amplified previously from the pcDNA3.1 vector [Invitrogen]) (unpublished data). Standard recombinant DNA methods (43) or procedures specified by the manufacturer were used. The resulting plasmid, designated lpp1/V5/His-dsRed, was verified by DNA sequencing with appropriate vector-specific primers.
Expression and purification of recombinant Lpp1.
E. coli DH5
harboring the expression vector lpp1/V5/His-dsRed was grown at 37°C in 100 ml of BHI medium with 100 µg/ml ampicillin until an optical density at 600 nm of 0.2 was obtained. Protein expression was induced by the addition of 1 mM isopropyl-β-D-thiogalactopyranoside and incubated for 12 h at 37°C. The bacteria were harvested by centrifugation (10 min at 6,500 x g), and the bacterial pellets were resuspended in 10 ml of 50 mM NaH2PO4, 300 mM NaCl buffer (pH 8.0). The bacterial cells were disrupted by sonication (two times for 45 s each time), and the lysates were centrifuged at 10,000 x g for 10 min. The supernatants were loaded onto Ni-nitrilotriacetic acid-agarose columns equilibrated with the same buffer. The columns were washed with 50 mM NaH2PO4, 300 mM NaCl buffer (pH 8.0) containing 20 mM imidazole. Bound recombinant proteins were eluted from the columns using an imidazole gradient (100 mM, 200 mM, and 400 mM). Eluted proteins were dialyzed for 1 h against water and then overnight against PBS. The proteins were concentrated using Centricon YM-10 columns (Millipore). Protein concentrations in the samples were determined by bicinchoninic acid assay (Pierce).
Anti-Lpp1 antibody preparation. Purified recombinant Lpp1 (rLpp1) was used to raise antibodies in chickens by the method of Schwarzkopf et al. (44). Briefly, 100 µg of purified rLpp1 resuspended in 500 µl of PBS was mixed with an equal volume of Freund complete adjuvant, emulsified, and injected intramuscularly in four separate locations in single-combed White Leghorn laying hens (1 ml per bird). A booster injection prepared with incomplete adjuvant was given to the hen 1 week after the initial injection. The eggs from days 19 to 21 were collected, and antibodies were purified from egg yolks by the polyethylene glycol (PEG 8000; Fisher) precipitation method (37).
Enzyme-linked immunosorbent assay (ELISA). BBEC monolayers in 96-well plates were washed with Hank's balanced salt solution (HBSS) and blocked with 1% bovine serum albumin (BSA; Pierce) for 45 min. Increasing amounts of purified recombinant Lpp1 in HBSS were added to the wells and incubated for 1 h with gentle shaking. The monolayers were washed three times with HBSS and incubated with a 1:5,000 dilution of HRP-conjugated anti-V5 antibody (Invitrogen) for another hour. After plates were washed, the reaction was developed with TMB (3,3',5,5'-tetramethylbenzidine; Pierce), and the absorbance was read at 450 nm. For inhibition studies, rLpp1 (1 µM) was preincubated with increasing amounts of chicken anti-rLpp1 antibody for 45 min at room temperature in a total volume of 100 µl.
Flow cytometry. Overnight cultures of M. haemolytica were centrifuged, washed three times with PBS, and resuspended in PBS. The bacterial cells (5 x 108 CFU in 0.3 ml of PBS) were incubated with an equal volume of 4% paraformaldehyde (Sigma) at room temperature for 20 min. The fixed bacterial cells were then washed two times with PBS and incubated with 2% BSA (Pierce) for 45 min to block nonspecific binding. To detect Lpp1, bacterial cells were incubated for 1.5 h with chicken anti-rLpp1 antibody (1 µg/ml in PBS in a final volume 0.3 ml). As a control, bacterial cells were similarly incubated with irrelevant chicken immunoglobulin Y (IgY) antibody. The bacterial cells were then washed two times with PBS and incubated at room temperature for 1 h in the dark with FITC-conjugated goat anti-chicken IgY (diluted 1:250; Promega) and propidium iodide (5 µg/ml). The bacterial cells were washed three times with PBS and resuspended in PBS at a final concentration of 5 x 106 cells per ml. Flow cytometry analysis of 100,000 events was performed using a FACScan (Becton Dickinson).
Confocal microscopy.
M. haemolytica cells (
108) were washed with PBS, incubated at room temperature on glass coverslips for 10 min, and fixed on the coverslips with 4% paraformaldehyde (Sigma) for 20 min. After three washes with PBS, nonspecific binding was blocked by incubation of slides with 2% BSA (Pierce) in PBS for 45 min. To detect Lpp1, bacteria were incubated for 1.5 h with chicken anti-rLpp1 antibody or irrelevant chicken IgY antibody as control, followed by FITC-conjugated goat anti-chicken IgY (diluted 1:250; Promega). Fluorescence was visualized by laser scanning confocal microscopy using an Eclipse TE200-U microscope (Nikon).
Inhibition assay. M. haemolytica suspensions (107 CFU per 100 µl of RPMI medium) were preincubated with different dilutions (1:300, 1:70, and 1:35) of bovine anti-OmpA or chicken anti-rLpp1 antibodies for 45 min at room temperature. Bacteria were added to BBEC monolayers in 96-well tissue culture plates and incubated for 1 h at 37°C. Normal bovine and rabbit sera were used as controls. After five washes with RPMI, BBEC were lysed with 1% saponin (Sigma) for 20 min. Bacteria in the cell lysates were suspended by vigorous pipetting, and the numbers of CFU were determined by plating of serial dilutions on blood agar. Control experiments demonstrated that saponin treatment did not have a deleterious effect on M. haemolytica viability as determined by CFU counts.
Statistical analysis. Data are presented as the means ± standard errors of the means (SEM). Analysis of variance followed by a Tukey posttest for significance was performed using the Prism 5 (GraphPad) statistical software package.
|
|
|---|
. Following a 2-h incubation, the relative number of adherent E. coli DH5
cells was 51% ± 7.6% (mean ± SEM of three separate experiments; P < 0.05) of the number of M. haemolytica cells (data not shown). We also investigated whether M. haemolytica was internalized by BBEC using a gentamicin protection assay. We did not recover any CFU of M. haemolytica after gentamicin treatment of BBEC monolayers incubated with bacteria for 1 h and 3 h at 37°C (data not shown). These results suggest that M. haemolytica did not invade BBEC during these times of incubation.
![]() View larger version (40K): [in a new window] |
FIG. 1. Adherence of M. haemolytica to BBEC. Primary cultures of BBEC were incubated with FITC-labeled M. haemolytica (A), FITC-labeled M. haemolytica preincubated with a 1:100 dilution of rabbit anti-M. haemolytica antibody (B), or FITC-labeled M. haemolytica preincubated with a 1:100 dilution of normal rabbit serum (C). BBEC were incubated with bacteria at an MOI of 100:1 for 2 h at 37°C. After several washes to remove unbound bacteria, cell-associated bacteria were visualized by fluorescence microscopy using an Olympus IX70 microscope (Olympus). Photos are representative of three independent experiments.
|
30 kDa and a minor protein band with a molecular mass of
90 kDa (Fig. 2B). Similar protein bands were observed when the blot was probed with anti-M. haemolytica antibody although an additional minor band with a molecular mass of
60 kDa was also detected (Fig. 2C). In contrast, no protein bands were identified when BBEC were incubated with biotin-labeled proteins from E. coli DH5
as a control (data not shown). This observation is consistent with data showing relatively less adherence of E. coli DH5
to BBEC. To exclude the possibility that inefficient biotinylation of surface proteins affected the observed profiles of adhesive proteins, M. haemolytica OMPs were isolated, labeled with biotin, and tested for binding to BBEC monolayers. As shown in Fig. 3C (lane 1), staining with anti-biotin antibody consistently detected a dominant protein band of
30 kDa. In some experiments additional minor bands were observed with molecular mass of 18 kDa, 37 kDa, and 45 kDa (data not shown). As described in Materials and Methods, BBEC monolayers with bound bacterial proteins were lysed with M-PER. Interestingly, when BBEC monolayers were solubilized with Laemmli buffer, Western blotting revealed additional
37-kDa protein bands (Fig. 3C, lane 2). Similar heterogenic migration of bacterial proteins in SDS-PAGE has been described for the OmpA protein family (2, 49, 31, 53). OmpA can undergo conformational changes when heated in the presence of SDS or 2-mercaptoethanol and migrates in the gel in two forms (2, 49). The apparent molecular mass reported for M. haemolytica OmpA is 38 kDa for the denatured form and 30 kDa for the incompletely denatured form (55). Because the molecular masses of the protein bands we detected by Western blotting with anti-biotin antibody were similar to the molecular mass of OmpA, we hypothesized that the 30-kDa BBEC-binding proteins might represent OmpA of M. haemolytica.
![]() View larger version (31K): [in a new window] |
FIG. 2. Binding of biotinylated M. haemolytica surface proteins to BBEC monolayers. Panel A illustrates Western blot analysis of a total cell lysate (5 µg) of biotinylated M. haemolytica cells probed with HRP-conjugated anti-biotin antibody. In panels B to D, BBEC monolayers were incubated with lysates of biotinylated M. haemolytica cells for 2 h at room temperature. After a washing step, cell monolayers were lysed with M-PER, and total lysates were separated in 4 to 20% gradient gels. The proteins were transferred to nitrocellulose and probed with HRP-conjugated anti-biotin antibody (B and D) or anti-M. haemolytica antibody (C). Lanes in panels B and C are as follows: lane 1, BBEC control; lane 2, BBEC incubated with 100 µg of bacterial proteins; lane 3, BBEC incubated with 200 µg of bacterial proteins. In panel D, native (lane 1) and fixed (lane 2) BBEC were incubated with 200 µg of bacterial proteins. Data are representative of three independent experiments. Molecular mass markers (in kDa) are shown on the right.
|
![]() View larger version (57K): [in a new window] |
FIG. 3. Binding of biotinylated M. haemolytica OMPs to BBEC monolayers. (A) Biotinylated M. haemolytica OMPs (10 µg) stained with Coomassie blue. (B) Biotinylated M. haemolytica OMPs (1 µg) probed with HRP-conjugated anti-biotin antibody. (C) BBEC monolayers incubated with 30 µg of biotinylated M. haemolytica OMPs for 2 h at room temperature. After a washing step, cell monolayers were lysed with M-PER (lane 1) or Laemmli buffer (lane 2), and total lysates were separated in 4 to 20% gradient gels. The proteins were transferred to nitrocellulose and probed with HRP-conjugated anti-biotin antibody. Data are representative of three independent experiments. Molecular mass markers (in kDa) are shown on the right.
|
M. haemolytica OMPs that bound to the fixed BBEC were eluted with M-PER, concentrated, and then separated by 2-DE. Examination of a Coomassie blue-stained gel revealed the presence of a major 30-kDa spot and additional spots with molecular masses of 14 and 43 kDa (Fig. 4B). These additional proteins (14 and 43 kDa) were not observed by SDS-PAGE when whole M. haemolytica lysate, instead of the OMP fraction, was used for binding to fixed BBEC (Fig. 5A). The 30-kDa protein spot was excised from the 2-DE gel and digested with trypsin, and the peptide masses were determined by LC-MS/MS. The MS/MS peptide ions were analyzed using the Mascot protein database, resulting in identification of the proteins listed in Table 1. These results showed that the greatest number of peptides matched with two M. haemolytica proteins: a heat-modifiable OMP (homologue of OmpA) and Lpp1. As a control, BBEC-binding proteins were separated by SDS-PAGE, and the 30-kDa protein band was excised from the gel and analyzed by LC-MS/MS. Using this approach, the same proteins, OmpA and Lpp1, were identified as dominant proteins. However, we also found additional peptide homologues of the OMP P2 of Actinobacillus pleuropneumoniae (data not shown). We also assessed the identity of the
43-kDa protein spot shown in Fig. 4 by LC-MS/MS. A homology search of the protein database identified this protein as OMP44 of M. haemolytica, with high homology of this protein to bacterial porins identified in other Pasteurellaceae family members (OmpH of Pasteurella multocida and OMP P2 of H. influenzae). To confirm the results obtained by LC-MS/MS for a 30-kDa spot, bacterial BBEC-binding proteins were blotted and probed with bovine polyclonal anti-M. haemolytica OmpA and chicken anti-M. haemolytica rLpp1 antibodies. This analysis showed that the 30-kDa protein band was recognized by both antibodies (Fig. 5B and C).
![]() View larger version (27K): [in a new window] |
FIG. 4. 2-DE of M. haemolytica OMPs eluted from fixed BBEC. (A) SDS-PAGE analysis of M. haemolytica OMPs stained with Coomassie blue prior to incubation with BBEC. (B) M. haemolytica OMPs eluted from fixed BBEC were separated by 2-DE using pH 3.5 to 10 immobilized pH gradient strips and 12.5% SDS-PAGE. The proteins were stained with Coomassie blue. The circled 30-kDa protein spot was excised and analyzed by LC-MS/MS. The proteins identified in this spot are listed in Table 1. The positions of molecular mass markers (in kDa) are indicated on the right. The black arrowhead indicates the tropomyosin standard with pI 5.2 and molecular mass of 32.7 kDa.
|
![]() View larger version (67K): [in a new window] |
FIG. 5. SDS-PAGE and Western blot analysis of M. haemolytica proteins that bind to BBEC. Fixed monolayers of BBEC were incubated with unlabeled M. haemolytica proteins (1 mg/ml) overnight at 4°C. After a washing step, bacterial proteins were eluted using Laemmli buffer, concentrated, and separated in 4 to 20% gradient gels. The proteins were stained with Coomassie blue (A) or transferred to nitrocellulose. The blotted proteins were probed with bovine anti-M. haemolytica OmpA (B) or chicken anti-rLpp1 (C) antibodies followed by appropriate HRP-conjugated secondary antibodies. The arrow indicates the M. haemolytica proteins eluted from the fixed BBEC monolayers. Data are representative of three independent experiments. Molecular mass markers (in kDa) are shown on the left.
|
|
View this table: [in a new window] |
TABLE 1. BBEC bound proteins identified by LC-MS/MS for the 30-kDa 2-DE protein spot
|
. As shown in Fig. 6, after rLpp1 was purified on Ni-nitrilotriacetic acid agarose, the recombinant protein was recognized by V5-specific and rLpp1-specific antibodies. Binding of rLpp1 to BBEC was assessed by Western blotting and a cell ELISA method. As shown in Fig. 7A and B, rLpp1 bound to BBEC monolayers. The cell ELISA method showed that rLpp1 binding to BBEC was dose dependent, saturable at approximately 1 µM, and significantly inhibited by chicken anti-rLpp1 antibodies (Fig. 7B and C).
![]() View larger version (28K): [in a new window] |
FIG. 6. SDS-PAGE and Western blot analysis of rLpp1. Purified rLpp1 (2 µg) was separated in 4 to 20% gradient gels. The proteins were stained with Coomassie blue (A) or transferred to nitrocellulose and probed with HRP-conjugated anti-V5 (B) or chicken anti-Lpp1 (C) antibodies. Data are representative of three independent experiments. Molecular mass markers (in kDa) are shown on the left.
|
![]() View larger version (15K): [in a new window] |
FIG. 7. Binding of rLpp1 to BBEC. (A) BBEC monolayers were incubated with 50 µg purified rLpp1 (lane 1) or with HBSS (lane 2) for 2 h at room temperature. BBEC were lysed with M-PER, and total lysates were separated in 4 to 20% gradient gels. The proteins were transferred to nitrocellulose and probed with HRP-conjugated anti-V5 antibody. Molecular mass markers (in kDa) are shown on the left. (B) BBEC cell monolayers in 96-well plates were incubated with increasing concentrations of purified rLpp1 for 1 h at room temperature. Cells then were incubated with HRP-conjugated anti-V5 antibody. The reaction was developed using TMB, and absorbance was read at 450 nm. (C) rLpp1 (1 µM) was preincubated with increasing amounts of anti-Lpp1 antibody before being incubated with BBEC for 1 h at room temperature. Panel A is a photograph of a representative blot from one of three independent experiments. In panels B and C, data are the mean ± SEM of triplicate wells from one representative experiment of three independent experiments that were performed. *, P < 0.05 compared to control (no antibody). OD, optical density.
|
![]() View larger version (26K): [in a new window] |
FIG. 8. Detection of Lpp1 on the surface of M. haemolytica cells. (A) Flow cytometry analysis of M. haemolytica cells stained with chicken anti-rLpp1 antibody and FITC-conjugated anti-chicken IgY. (B to D) The expression of Lpp1 on the surface of M. haemolytica was analyzed by laser scanning confocal microscopy at an emission wavelength of 488 nm. M. haemolytica cells were stained with chicken anti-rLpp1 antibody (B and C) or an irrelevant chicken IgY (D) as a control and then incubated with FITC-conjugated anti-chicken IgY antibody. Photos are representative of three independent experiments. Magnifications, x200 (B and D) and x1,500 (C). Ab, antibody.
|
![]() View larger version (27K): [in a new window] |
FIG. 9. Inhibition of M. haemolytica adherence to BBEC by anti-OmpA or anti-Lpp1 antibodies. M. haemolytica cells were preincubated with different dilutions (1: 300, 1:70, and 1: 35) of bovine anti-OmpA or chicken anti-rLpp1 antibodies for 45 min at room temperature. BBEC incubated with normal rabbit serum or RPMI medium were included as controls. Bacteria were added to BBEC monolayers in 96-well tissue culture plates and incubated for 1 h at 37°C. After plates were washed with RPMI medium, BBEC were lysed with 1% saponin followed by serial dilution and plating on blood agar. Data are the mean ± SEM of triplicate wells from one representative experiment of three experiments that were performed. *, P < 0.05 compared to control.
|
|
|
|---|
LC-MS/MS analysis of the 30-kDa BBEC-binding proteins identified at least two M. haemolytica surface proteins: a heat-modifiable OMP (homologue of OmpA) and Lpp1. OmpA is one of the major OMPs in gram-negative bacteria. OmpA has been reported to be involved in bacterial adherence and invasion and also activation of host defense mechanisms for many gram-negative pathogens (4, 16, 36, 38, 45). For example, OmpA of meningitis-causing E. coli contributes to invasion of human brain microvascular endothelial cells in vitro (27, 38, 39). Klebsiella pneumoniae OmpA binds to and activates human bronchial epithelial cells, macrophages, and dendritic cells (24, 36, 48). Intratracheal injection of purified K. pneumoniae OmpA into mice results in lung neutrophilia (36). The recent reports of Choi et al. (5, 6) showed that OmpA can act as a potential virulence factor during infection caused by Acinetobacter baumanni. The direct binding and subsequent subcellular targeting of A. baumanni OmpA induced apoptosis of host cells in vitro and in vivo. Adhesive properties of OmpA have also been identified in members of the Pasteurellaceae family. For example, the OmpA of nontypeable H. influenzae (P5 protein) binds to human nasopharyngeal mucin and carcinoembryonic antigen-related cell adhesion molecules (4, 22, 41). Recognition of host receptors by P5 appears to be critical for adherence of nontypeable H. influenzae to A549 lung epithelial cells and nasopharynx colonization of chinchillas (4, 25, 47). Dabo et al. (12) demonstrated interaction of the recombinant OmpA of P. multocida with Madin-Darby bovine kidney cells and extracellular matrix molecules such as heparin and fibronectin. Fibronectin-binding activity has also been reported for OmpA from M. haemolytica (29). In our study, we show that M. haemolytica OmpA binds to BBEC. Preincubation of M. haemolytica cells with anti-OmpA antibody significantly reduced bacterial binding to BBEC, suggesting that OmpA interaction with BBEC is important for M. haemolytica adherence.
Interestingly, we identified another M. haemolytica protein, Lpp1, which binds to BBEC and migrates in SDS-PAGE together with OmpA. M. haemolytica Lpp1 (also known as PlpA or Plp1) represents one of three very similar membrane lipoproteins with molecular masses of 28 to 30 kDa (9). Each of these three lipoproteins was immunogenic and recognized by serum from calves naturally exposed to M. haemolytica or vaccinated with live or killed M. haemolytica (11). Furthermore, the serum antibody response against recombinant Lpp1 or Lpp3 correlated with resistance of calves to M. haemolytica-induced pneumonic pasteurellosis (10, 11). In vitro investigation demonstrated that an M. haemolytica mutant that was unable to produce these three lipoproteins was more susceptible to bovine complement-mediated killing (35). The strong reaction of antiserum raised against whole M. haemolytica cells with these lipoproteins suggested that they are exposed on the surface of the bacterial cells. However, the surface localization and adhesive properties of these lipoproteins were not specifically investigated. Our work demonstrates that purified rLpp1 binds to BBEC monolayers in a dose-dependent manner and that binding of rLpp1 and M. haemolytica cells to BBEC was inhibited by anti-rLpp1 antibody. Furthermore, we show by flow cytometry and confocal microscopy that Lpp1 was localized on the surface of M. haemolytica cells. Although the amino acid sequence of Lpp1 shows no homology with any known adhesin, our results suggest that Lpp1 can contribute to M. haemolytica adherence to BBEC. Comparison of the Lpp1 sequence with the NCBI protein database indicates that Lpp1 is strongly related to the ATP-binding cassette (ABC) transporters. A previous report described a 68-kDa adhesin of M. haemolytica that binds to bovine tracheal epithelial cells and neutrophils (23). Interestingly, BLAST analysis of this protein's N-terminal sequence (ANEVNVYIYKQPYLI) identified it as an iron binding protein with homology to iron (III) ABC transporters. Several other ABC transporters involved in nutrient or metal ion uptake have been reported to contribute to adherence of pathogenic bacteria to their host cells. For example, adherence of Streptococcus pneumoniae to nasopharyngeal cells and type II pneumocytes was mediated by PsaA lipoprotein, which is a member of the ABC transporter family implicated in manganese transport (3, 32, 42). Similarly, the glutamine ABC transporter (product of glnQ) of group B streptococcus contributed to binding and invasion of respiratory epithelial cells in vitro and virulence in an experimental animal model (50). Although the ABC transporter function of M. haemolytica Lpp1 remains unknown, we infer that, like other ABC transporters, Lpp1 may participate in bacterial adhesion.
Homologues of both M. haemolytica OmpA and Lpp1 are reported to be major protein components of leukotoxin-enriched outer membrane vesicles produced by Aggregatibacter actinomycetemcomitans, another member of the Pasteurellaceae family (26). These vesicles are thought to represent a vehicle for the in vivo delivery of virulence factors to susceptible host cells (28). Although the mechanism involved in the interaction of bacterial vesicles with target cells is not fully understood, it has been shown that association of A. actinomycetemcomitans vesicles with HL60 cells is independent of leukotoxin (15). Therefore, it is tempting to speculate that the adhesive properties of vesicle-associated OmpA or Lpp1 of A. actinomycetemcomitans are responsible for attachment of leukotoxin-containing particles to target cell membranes. Similarly, perhaps M. haemolytica OmpA or Lpp1 is involved in delivery of leukotoxin to bovine leukocytes.
In our experiments we consistently identified 30-kDa M. haemolytica proteins as dominant adhesive proteins. In some experiments we also detected other M. haemolytica proteins associated with BBEC. For example, Western blot analyses with biotinylated M. haemolytica surface proteins showed the presence of a minor 90-kDa protein band that was recognized by anti-M. haemolytica antibody. However, this protein band was not detected when unbiotinylated total bacterial lysates or isolated OMP fractions were used in binding assays. One potential explanation for these results is that the 90-kDa band represents a trimer of OmpA. However, we cannot exclude the possibility that the 90-kDa band represents some other adhesive protein of M. haemolytica. Additional protein spots (
43 kDa and 14 kDa) were also observed in our 2D analysis of M. haemolytica OMP associated with BBEC monolayers. When the 43-kDa spot was analyzed by LC-MS/MS, a homology search of the NCBI protein database identified this protein as OMP44 of M. haemolytica that shows high homology to bacterial porins (OmpH and OMP P2) identified in other Pasteurellaceae family members. These results could explain the observation that anti-OmpA and anti-Lpp1 antibodies only partially inhibited M. haemolytica binding to BBEC. Therefore, we cannot exclude the possibility that other adhesive proteins are involved in M. haemolytica adherence to bovine bronchial epithelial cells.
In summary, our results demonstrate that OmpA and Lpp1 contribute to adherence of M. haemolytica to BBEC in vitro. Additional studies are required to define the receptors on bovine respiratory epithelial cells that are involved in M. haemolytica binding. Defining the mechanisms by which M. haemolytica interacts with respiratory tract epithelial cells will provide new insight into the pathogenesis of the bovine respiratory disease complex.
This work was supported by National Research Initiative Competitive Grants 2004-35204-14841 and 2006-35204-17522 from the USDA Cooperative State Research, Education, and Extension Service and by the Walter and Martha Renk Endowed Laboratory for Food Safety.
Published ahead of print on 3 November 2008. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»